Literature DB >> 20970515

Similar gene expression profiles in smokers and patients with moderate COPD.

Laia Llinàs1, Victor I Peinado, J Ramon Goñi, Roberto Rabinovich, Sandra Pizarro, Robert Rodriguez-Roisin, Joan Albert Barberà, Ricardo Bastos.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by multiple cellular and structural changes affecting the airways, lung parenchyma and vasculature, some of which are also identified in smokers without COPD. The molecular mechanisms underlying these changes remain poorly understood. With the aim of identifying mediators potentially implicated in the pathogenic processes that occur in COPD and their potential relationship with cigarette smoking, we evaluated the mRNA expression of genes involved in inflammation, tissue remodeling and vessel maintenance. Lung tissue samples were obtained from 60 patients who underwent lung resection (nonsmokers, n=12; smokers, n=12; and moderate COPD, n=21) or lung transplant (severe-to-very severe COPD, n=15). PCR arrays containing 42 genes coding for growth factors/receptors, cytokines, metalloproteinases, adhesion molecules, and vessel maintenance mediators were used. Smoking-induced changes include the up-regulation of inflammatory genes (IL-1β, IL-6, IL-8, CCL2, and CCL8) and the decreased expression of growth factor/receptor genes (BMPR2, CTGF, FGF1, KDR and TEK) and genes coding for vessel maintenance factors (EDNRB). All these genes exhibited a similar profile in moderate COPD patients. The up-regulation of MMP1 and MMP9 was the main change associated with COPD. Inflammatory genes as well as the endothelial selectin gene (SELE) were down-regulated in patients with more severe COPD. Clustering analysis revealed a closer relationship between moderate COPD and smokers than between both subsets of COPD patients for this selected set of genes. The study reveals striking similarities between smokers and COPD patients with moderate disease emphasizing the crucial role of cigarette smoking in the genesis of these changes, and provides additional evidence of the involvement of the matrix metalloproteinase's in the remodeling process of the lung in COPD.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970515     DOI: 10.1016/j.pupt.2010.10.010

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  18 in total

Review 1.  Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.

Authors:  Joan Albert Barberà; Isabel Blanco
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

2.  MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.

Authors:  Melina M Musri; Núria Coll-Bonfill; Bradley A Maron; Víctor I Peinado; Rui-Sheng Wang; Jordi Altirriba; Isabel Blanco; William M Oldham; Olga Tura-Ceide; Jessica García-Lucio; Benjamin de la Cruz-Thea; Gunter Meister; Joseph Loscalzo; Joan A Barberà
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 6.914

3.  Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease.

Authors:  Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano
Journal:  COPD       Date:  2013-08       Impact factor: 2.409

4.  Regulation of Wnt4 in chronic obstructive pulmonary disease.

Authors:  Andrew L Durham; Alistair McLaren; Brian P Hayes; Gaetano Caramori; Chris L Clayton; Peter J Barnes; K Fan Chung; Ian M Adcock
Journal:  FASEB J       Date:  2013-03-05       Impact factor: 5.191

5.  A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese Population.

Authors:  Jian Wang; Chenting Zhang; Zili Zhang; Zeguang Zheng; Dejun Sun; Quan Yang; Cyrus Hadadi; Defu Li; Xiaoming Xu; Mingmei Xiong; Qipeng Zhou; Meihua Guo; Yingfeng Wang; Chun Tang; Guihua Xu; Kai Yang; Nanshan Zhong; Wenju Lu
Journal:  EBioMedicine       Date:  2016-02-05       Impact factor: 8.143

6.  Expression variations of connective tissue growth factor in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.

Authors:  Si-jing Zhou; Min Li; Da-xiong Zeng; Zhong-ming Zhu; Xian-wei Hu; Yong-huai Li; Ran Wang; Geng-yun Sun
Journal:  Sci Rep       Date:  2015-02-24       Impact factor: 4.379

7.  Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension.

Authors:  Joan Albert Barberà
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

8.  Persistence of systemic inflammation in COPD in spite of smoking cessation.

Authors:  Giovanni Invernizzi
Journal:  Multidiscip Respir Med       Date:  2011-08-31

9.  Differential Gene Expression in Colon Tissue Associated With Diet, Lifestyle, and Related Oxidative Stress.

Authors:  Martha L Slattery; Daniel F Pellatt; Lila E Mullany; Roger K Wolff
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 10.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.